Literature DB >> 25783508

(18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.

Christos Sachpekidis1, Elias K Mai, Hartmut Goldschmidt, Jens Hillengass, Dirk Hose, Leyun Pan, Uwe Haberkorn, Antonia Dimitrakopoulou-Strauss.   

Abstract

PURPOSE: The value of F-FDG PET in the diagnostic approach of multiple myeloma (MM) remains incompletely elicited. Little is known about the kinetics of F-FDG in the bone marrow and extramedullary sites in MM. This study aimed to evaluate quantitative data on kinetics and distribution patterns of F-FDG in MM patients with regard to pelvic bone marrow plasma cell infiltration. PROCEDURES: The study included 40 patients with primary MM. Dynamic PET/CT scanning of the lower lumbar spine and pelvis was performed after the administration of F-FDG. Whole-body PET/CT studies were performed. Sites of focal increased tracer uptake were considered as highly suggestive of myelomatous involvement after taking into account the patient history and CT findings. Bone marrow of the os ilium without pathologic tracer accumulation served as reference. The evaluation of dynamic PET/CT studies was based in addition to the conventional visual (qualitative) assessment, on semiquantitative (SUV) calculations, as well as on absolute quantitative estimations after application of a 2-tissue compartment model and a noncompartmental approach. F-FDG quantitative information and corresponding distribution patterns were correlated with pelvic bone marrow plasma cell infiltration.
RESULTS: Fifty-two myelomatous lesions were detected in the pelvis. All parameters in suspected MM lesions ranged in significantly higher levels than in reference tissue (P < 0.01). Correlative analyses revealed that bone marrow plasma cell infiltration rate correlated significantly with SUVaverage, SUVmax, and the parameters K1, influx, and fractal dimension of F-FDG in reference bone marrow (P < 0.01). In addition, whole-body static PET/CT imaging demonstrated 4 patterns of tracer uptake; these are as follows: negative, focal, diffuse, and mixed (focal/diffuse) tracer uptake. Patients with a mixed pattern of radiotracer uptake had the highest mean plasma cell infiltration rate in their bone marrow, whereas those with negative PET/CT scans demonstrated the lowest bone marrow plasma cell infiltration. In total, 265 focal myeloma-indicative F-FDG-avid lesions were detected, 129 of which correlated with low-dose CT osteolytic findings. No significant correlation between the number of focal lesions detected in PET/CT and bone marrow infiltration was detected.
CONCLUSIONS: The F-FDG kinetic parameters K1, influx, and fractal dimension as well as SUVaverage from reference tissue correlated significantly with bone marrow malignant plasma cell infiltration rate. Patients with negative PET/CT demonstrated the lowest bone marrow infiltration by malignant plasma cells, whereas those with a mixed pattern of tracer uptake had the highest infiltration.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25783508     DOI: 10.1097/RLU.0000000000000773

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  9 in total

1.  Quantitative Analysis of Heterogeneous [18F]FDG Static (SUV) vs. Patlak (Ki) Whole-body PET Imaging Using Different Segmentation Methods: a Simulation Study.

Authors:  Mingzan Zhuang; Nicolas A Karakatsanis; Rudi A J O Dierckx; Habib Zaidi
Journal:  Mol Imaging Biol       Date:  2019-04       Impact factor: 3.488

2.  Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma.

Authors:  Christos Sachpekidis; Maximilian Merz; Annette Kopp-Schneider; Anna Jauch; Marc-Steffen Raab; Sandra Sauer; Jens Hillengass; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Haematologica       Date:  2019-02-14       Impact factor: 9.941

3.  Prognostic significance of normalized FDG-PET parameters in patients with multiple myeloma undergoing induction chemotherapy and autologous hematopoietic stem cell transplantation: a retrospective single-center evaluation.

Authors:  Daria Ripani; Carmelo Caldarella; Tommaso Za; Daniele Antonio Pizzuto; Elena Rossi; Valerio De Stefano; Alessandro Giordano
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-27       Impact factor: 9.236

4.  Treatment response evaluation with 18F-FDG PET/CT and 18F-NaF PET/CT in multiple myeloma patients undergoing high-dose chemotherapy and autologous stem cell transplantation.

Authors:  Christos Sachpekidis; J Hillengass; H Goldschmidt; B Wagner; U Haberkorn; K Kopka; A Dimitrakopoulou-Strauss
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-08-29       Impact factor: 9.236

5.  18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.

Authors:  Mohammed Shah Alam; Lilan Fu; Yun-Yan Ren; Hu-Bing Wu; Quan-Shi Wang; Yan-Jiang Han; Wen-Lan Zhou; Hong-Sheng Li; Zhen Wang
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

6.  A predicting model of bone marrow malignant infiltration in 18F-FDG PET/CT images with increased diffuse bone marrow FDG uptake.

Authors:  Mingge Zhou; Yumei Chen; Jianjun Liu; Gang Huang
Journal:  J Cancer       Date:  2018-04-19       Impact factor: 4.207

7.  Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?

Authors:  Christos Sachpekidis; Annette Kopp-Schneider; Maximilian Merz; Anna Jauch; Marc-Steffen Raab; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Cancers (Basel)       Date:  2020-05-23       Impact factor: 6.639

8.  Functional Imaging with 18F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient.

Authors:  Christos Sachpekidis; Antonia Dimitrakopoulou-Strauss; Stefan Delorme; Hartmut Goldschmidt
Journal:  Diagnostics (Basel)       Date:  2017-12-15

Review 9.  Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.

Authors:  Christos Sachpekidis; Hartmut Goldschmidt; Antonia Dimitrakopoulou-Strauss
Journal:  Molecules       Date:  2019-12-29       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.